Biblio
Export 1937 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is B [Clear All Filters]
“Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1057-1074, 2023.
, “Extracellular Tau Oligomers Damage the Axon Initial Segment.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1425-1441, 2023.
, “Extracellular Tau Oligomers Damage the Axon Initial Segment.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1425-1441, 2023.
, “From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology.”, J Alzheimers Dis, vol. 94, no. s1, pp. S87-S96, 2023.
, “Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 3, pp. 1135-1151, 2023.
, “Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 3, pp. 1135-1151, 2023.
, “Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1047-1056, 2023.
, “Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1229-1239, 2023.
, “The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.”, J Alzheimers Dis, vol. 95, no. 2, pp. 703-718, 2023.
, “Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 2, pp. 813-825, 2023.
, “Linking Air Pollution Exposure to Blood-Based Metabolic Features in a Community-Based Aging Cohort with and without Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1025-1040, 2023.
, “Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 91, no. 1, pp. 273-290, 2023.
, “Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1051-1058, 2023.
, “Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1051-1058, 2023.
, “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
, “Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1505-1514, 2023.
, “Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.”, J Alzheimers Dis, vol. 94, no. 1, pp. 101-113, 2023.
, “Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1607-1615, 2023.
, “Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 471-481, 2023.
, “Mitochondria Profoundly Influence Apolipoprotein E Biology.”, J Alzheimers Dis, vol. 92, no. 2, pp. 591-604, 2023.
, “Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1173-1182, 2023.
, “Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1173-1182, 2023.
, “Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
, “MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample.”, J Alzheimers Dis, vol. 96, no. 1, pp. 103-112, 2023.
, “Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.”, J Alzheimers Dis, vol. 96, no. 2, pp. 683-693, 2023.
,